WebApr 2, 2024 · Comella has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aeon. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. WebDr. Comella earned her bachelors degree in biochemistry from Smith College, and her medical degree from the University of Cincinnati. She is currently a professor of neurological sciences at Rush University Medical Center and is board certified in neurology and sleep medicine. She is an expert on Parkinson's disease, dystonia, and other movement …
Did you know?
WebRaw scores for GEC, MI, and BRI (sum of 70, 40, and 30 items, respectively) were converted to a T-score (mean=50, standard deviation=10;T-score≥65consideredabnormallyelevated)and WebAug 1, 2010 · Matthew Menza, MD - Research Support: National Institutes of Health (NINDS), Astra-Zeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Forest Laboratories, ... Cynthia Comella, MD - Research Support: Boehringer Ingelheim, Allergan, Ipsen, Merz, National Institutes of Health (NINDS), Dystonia Study Group (DSG).
WebNov 5, 2024 · Cynthia Comella, MD. Professor Department of Neurological Sciences Rush University Medical Center Chicago, IL. Sherry A. Downie, PhD. Professor Emerita Department of Physical Medicine & Rehabilitation Albert Einstein College of Medicine Bronx, NY. Yeva M. Fernandez, MD. Web5. Treatment of cervical dystonia Reiner Benecke, Karen Frei and Cynthia L. Comella 6. Treatment of hemifacial spasm Karen Frei and Peter Roggenkaemper 7. Treatment of blepharospasm Carlo Colosimo, Dorine Tiple and Alfredo Barardelli 8. Treatment of oromandibular dystonia Francisco Cardoso, Roongroj Bhidayasiri and Daniel D. Truong 9.
WebCynthia L. Comella, MD, is Professor Emeritus in the Department of Neurological Sciences at Rush University Medical Center, Chicago, Illinois. She is board certified in Neurology …
WebCynthia L. Comella MD's 4 research works with 231 citations and 309 reads, including: Restless Legs Syndrome and Akathisia in Parkinson's Disease
WebCynthia Comella is a Neurologist in Chicago, Illinois. Comella has been practicing medicine for over 43 years and is highly rated in 22 conditions, according to our data. Her top areas of expertise are Drug Induced Dyskinesia, Torticollis, Focal Dystonia, Parkinson's Disease, and Deep Brain Stimulation. textron g784WebOct 2, 2012 · Cynthia Comella, Rush University Medical Center, Chicago IL. Stanley Fahn, Columbia University Medical Center, New York NY. Mark Hallett, National Institute of Neurological Disorders and Stroke, Bethesda MD. Joseph Jankovic, Baylor College of Medicine, Houston TX. Jorge L. Juncos, Emory University, Atlanta GA. textron fortune 500 rankinghttp://www.cdtorticollis.org/nsta-people/ textron flying clubWebCynthia Comella, MD is affiliated with Rush University Medical Center and specializes in Neurology Services in Chicago, IL Cynthia Comella, MD - Rush University Medical … textron fort worth txWebApr 12, 2004 · Cynthia Comella, A child with a severe movement disorder on the psychiatry unit, Movement Disorders, 10.3109/9780203008454-9, (31-34), (2013). Crossref Roger Dmochowski and Peter K. Sand , Botulinum toxin A in the overactive bladder: current status and future directions , BJU International , 99 , 2 , (247-262) , (2007) . textron fort worthWebDystonia is a Movement Disorder. The Dystonia Study Group is led by Cynthia Comella, MD. The Dystonia Study Group organizes and conducts clinical trials to test treatments for dystonia. The studies organized by the DSG have been integral to achieving conclusive information on the effectiveness of dystonia treatments and diagnostic tools. sw uk property cs1WebCynthia Comella, MD, FAAN Rush University Medical Center Chicago, Illinois The most effective treatment for blepharospasm is botulinum toxin injections. Oral medications have not been adequately evaluated in clinical trials for safety and efficacy in blepharospasm, and are not frequently used as a primary treatment. Anticholinergic drugs, textron g36